164 related articles for article (PubMed ID: 37520264)
1. DNAJ heat shock protein family member C1 can regulate proliferation and migration in hepatocellular carcinoma.
Fan YC; Meng ZY; Zhang CS; Wei DW; Wei WS; Xie XD; Huang ML; Jiang LH
PeerJ; 2023; 11():e15700. PubMed ID: 37520264
[TBL] [Abstract][Full Text] [Related]
2. EXOSC10 is a novel hepatocellular carcinoma prognostic biomarker: a comprehensive bioinformatics analysis and experiment verification.
Meng ZY; Fan YC; Zhang CS; Zhang LL; Wu T; Nong MY; Wang T; Chen C; Jiang LH
PeerJ; 2023; 11():e15860. PubMed ID: 37701829
[TBL] [Abstract][Full Text] [Related]
3. USP25 promotes hepatocellular carcinoma progression by interacting with TRIM21 via the Wnt/β-catenin signaling pathway.
Liu Y; Ma J; Lu S; He P; Dong W
Chin Med J (Engl); 2023 Sep; 136(18):2229-2242. PubMed ID: 37439386
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-20a-5p regulates the epithelial-mesenchymal transition of human hepatocellular carcinoma by targeting RUNX3.
Wang X; Wei P; Yang L; Liu F; Tong X; Yang X; Su L
Chin Med J (Engl); 2022 Sep; 135(17):2089-2097. PubMed ID: 35143426
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
6. The role of miR-99b in mediating hepatocellular carcinoma invasion and migration.
Liu CJ; Yang JH; Huang FZ; Yang JH; Liu CP; Mao XH; Yi WM; Shen XB; Peng C; Chen MF; Jiang B; Wu JS
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2273-2281. PubMed ID: 29762829
[TBL] [Abstract][Full Text] [Related]
7. RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway.
Shi R; Liu Z
Cancer Cell Int; 2022 Apr; 22(1):150. PubMed ID: 35410346
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9.
Gao J; Ding F; Liu Q; Yao Y
Mol Cell Biochem; 2013 Apr; 376(1-2):21-32. PubMed ID: 23232575
[TBL] [Abstract][Full Text] [Related]
9. [GPCR48 promotes invasion and metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma cells].
Peng QL; Wei SM; Zhang L; Gan LY; Xie Z; Qin J; Zhang Z; Wei JX
Zhonghua Gan Zang Bing Za Zhi; 2021 Sep; 29(9):849-854. PubMed ID: 34638203
[No Abstract] [Full Text] [Related]
10. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
[TBL] [Abstract][Full Text] [Related]
11. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
[TBL] [Abstract][Full Text] [Related]
12. Myricetin inhibits migration and invasion of hepatocellular carcinoma MHCC97H cell line by inhibiting the EMT process.
Ma H; Zhu L; Ren J; Rao B; Sha M; Kuang Y; Shen W; Xu Z
Oncol Lett; 2019 Dec; 18(6):6614-6620. PubMed ID: 31788118
[TBL] [Abstract][Full Text] [Related]
13. RIP1 upregulation promoted tumor progression by activating AKT/Bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC.
Wang C; Yao B; Xu M; Zheng X
Tumour Biol; 2016 Nov; 37(11):15305-15313. PubMed ID: 27699664
[TBL] [Abstract][Full Text] [Related]
14. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
15. Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma.
Wang Q; Yu X; Zheng Z; Chen F; Yang N; Zhou Y
PeerJ; 2021; 9():e11342. PubMed ID: 33987018
[TBL] [Abstract][Full Text] [Related]
16. TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway.
Huang DH; Jian J; Li S; Zhang Y; Liu LZ
Int J Mol Med; 2019 Dec; 44(6):2113-2122. PubMed ID: 31638175
[TBL] [Abstract][Full Text] [Related]
17. LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway.
Song XZ; Xu XJ; Ren XN; Ruan XX; Wang YL; Yao TT
Onco Targets Ther; 2020; 13():8907-8917. PubMed ID: 32982283
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma.
Jiang SS; Weng DS; Wang QJ; Pan K; Zhang YJ; Li YQ; Li JJ; Zhao JJ; He J; Lv L; Pan QZ; Xia JC
J Transl Med; 2014 Sep; 12():273. PubMed ID: 25260879
[TBL] [Abstract][Full Text] [Related]
19. Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling.
Lin J; Lin W; Ye Y; Wang L; Chen X; Zang S; Huang A
J Exp Clin Cancer Res; 2017 Sep; 36(1):134. PubMed ID: 28969700
[TBL] [Abstract][Full Text] [Related]
20. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
Xing Y; Liu Y; Qi Z; Liu Z; Wang X; Zhang H
Cell Mol Biol Lett; 2021 Nov; 26(1):49. PubMed ID: 34837962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
